GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Polar Capital Global Healthcare Trust PLC (LSE:PCGH) » Definitions » Research & Development

Polar Capital Global Healthcare Trust (LSE:PCGH) Research & Development : £0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Polar Capital Global Healthcare Trust Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Polar Capital Global Healthcare Trust's Research & Development for the six months ended in Mar. 2024 was £0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was £0.00 Mil.


Polar Capital Global Healthcare Trust Research & Development Historical Data

The historical data trend for Polar Capital Global Healthcare Trust's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polar Capital Global Healthcare Trust Research & Development Chart

Polar Capital Global Healthcare Trust Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Polar Capital Global Healthcare Trust Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Polar Capital Global Healthcare Trust Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Polar Capital Global Healthcare Trust  (LSE:PCGH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Polar Capital Global Healthcare Trust Research & Development Related Terms

Thank you for viewing the detailed overview of Polar Capital Global Healthcare Trust's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Polar Capital Global Healthcare Trust (LSE:PCGH) Business Description

Traded in Other Exchanges
Address
16 Palace Street, London, GBR, SW1E 5JD
Polar Capital Global Healthcare Trust PLC is a United Kingdom-based investment trust with an objective to generate capital growth by investing in a portfolio of healthcare stocks. It invests predominantly in listed equities issued by healthcare companies involved in pharmaceuticals, medical devices and biotechnology.

Polar Capital Global Healthcare Trust (LSE:PCGH) Headlines

No Headlines